Editorial Archive Archives - Page 23 of 39 - Journal for Clinical Studies

Current Edition

Editorial Archive

FDA Recommends Testing Drugs for Impacts on Driving Ability

New US Food and Drug Administration (FDA) draft guidance addresses when and how to evaluate drugs for the potential to impair driving ability, an issue that arises du...

12 May 2015 Editorial Archive | Volume 7 Issue 2 | Watch Pages V7 I2

Continue Reading →

Editorial Archive

Get Back – Managing your Return Logistics for Clinical Trials

Over the last ten years, the way that the pharmaceutical industry is expected to deliver new drug products to market has seen symbolic change. This shift in process h...

9 February 2015 Editorial Archive | Logistics V7 I1 | Volume 7 Issue 1

Continue Reading →

Editorial Archive

Mobile ePRO as a Cost-effective Method of Patient Data Capture

As digital technology plays an increasingly important part in our everyday lives, it comes as no surprise that it has a huge potential to address some of the key chal...

9 February 2015 Editorial Archive | Technology V7 I1 | Volume 7 Issue 1

Continue Reading →

Editorial Archive

Can mHealth be thought of as the Default Solution for Accelerating Completion and Increasing Success Outcomes in Clinical Trials?

Clinical trials are the experimental foundation on which modern medicine is built. Human medicines cannot be sold without permission from a licensing authority, and p...

9 February 2015 Editorial Archive | Technology V7 I1 | Volume 7 Issue 1

Continue Reading →

Editorial Archive

Understanding the Importance of Mobile Health for Pharma

Mobile health (mHealth) may be the buzzword of today, but unlike many other buzzwords, this one will not be just another flash in the pan. Mobile health offers the li...

9 February 2015 Editorial Archive | Technology V7 I1 | Volume 7 Issue 1

Continue Reading →

Editorial Archive

Pyoderma Gangrenosum: A Systemic Review of the Incidence and Prevalence

Pyoderma gangrenosum (PG) is a rare and serious skin disease in which a painful nodule breaks down to form progressive enlarging ulcers, and leads to a severe and sig...

9 February 2015 Editorial Archive | Therapeutics V7 I1 | Volume 7 Issue 1

Continue Reading →

Editorial Archive

Comparison of Marketing Authorisation and its Requirements for Brunei Darussalam and Indonesia

The availability of generic medication is an important issue in the ASEAN region. The regulatory requirements of various countries of the world vary from each other. ...

9 February 2015 Editorial Archive | Market Report V7 I1 | Volume 7 Issue 1

Continue Reading →

Editorial Archive

Centralised Monitoring: A Smart and Cost-efficient Approach

The clinical monitoring cost is one of the major costs and accounts for one-third of the overall cost of clinical trial management. As the complexities in clinical tr...

9 February 2015 Editorial Archive | Regulatory V7 I1 | Volume 7 Issue 1

Continue Reading →

Editorial Archive

Cardiac Safety Investigations 10 Years after ICH Guidance E14: – Evolving Industry and Regulatory Viewpoints on Evaluation of Proarrhythmic Risk during New Drug Development

The year 2015 marks the 10th anniversary of the release of two ICH Harmonised Tripartite Guidelines that have governed the cardiac safety regulatory landscape, more s...

9 February 2015 Editorial Archive | Regulatory V7 I1 | Volume 7 Issue 1

Continue Reading →

Editorial Archive

Overcoming Regulatory Challenges in Cognitive Drug Development

In recent years, numerous pharmaceutical and biotechnology companies have undertaken development programmes intended to assess the efficacy of various pro-cognitive d...

9 February 2015 Editorial Archive | Regulatory V7 I1 | Volume 7 Issue 1

Continue Reading →